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Abstract
Dendritic cells (DCs) play critical functions in the initiation of immune responses. Under-
standing their role in reactive arthritis (ReA) will help delineate the pathogenesis of
this arthropathy. In early studies, we detected IL-12/23p40 deregulation in Yersinia enter-
colitica (Ye)-induced ReA in TNFRp55-deficient (TNFRp55-/-) mice. In this study, we
assessed the contribution of DCs in this overproduction. First, greater levels of IL-12/
23p40, IFN-γand IL-17A were confirmed in supernatants of lipopolysaccharide (LPS)-stim-
ulated TNFRp55-/-splenocytes obtained on arthritis onset (day 14 after Ye infection).
Later, DCs were identified as a precise source of IL-12/23p40 since increased frequency
of splenic IL-12/23p40+DCs was detected in TNFRp55-/- mice. After robust in vivo amplifi-
cation of DCs by injection of Fms-like tyrosine kinase 3-Ligand (Flt3L)-transfected BL16
melanoma, DCs were purified. These cells recapitulated the higher production of IL-12/
23p40 under TNFRp55deficiency. In agreement with these results, TNFRp55-/- DCs pro-
moted Th1 and Th17 programs by co-culture with WT CD4+lymphocytes. A mechanistic
study demonstrated that JNK and p38 MAPK pathways are involved in IL-12/23p40 over-
production in purified TNFRp55-/- DCs as well as in the JAWS II cell line. This deregulation
was once again attributed to TNFRp55 deficiency since CAY10500, a specific inhibitor of
this pathway, compromised TNF-mediated IL-12/23p40 control in LPS-stimulated WT
DCs. Simultaneously, this inhibition reduced IL-10 production, suggesting its role mediat-
ing IL-12/23p40 regulation by TNFRp55 pathway. These results provide experimental
data on the existence of a TNFRp55-mediated anti-inflammatory circuit in DCs. Moreover,
these cells may be considered as a novel target in the treatment of ReA.
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Introduction
Reactive arthritis (ReA) is a form of seronegative spondyloarthritis (SpA) characterized by pre-
dominantly low limb asymmetric oligoarthritis and extra-articular symptoms following gastro-
intestinal or urogenital infection [1,2]. ReA most commonly affects young adults in the 20–40
year age range, and its incidence ranges between 1–30 cases/100.000 per year [1,3]. The clinical
symptoms of ReA manifest 1–3 weeks after infections and in contrast with septic arthritis the
blood or synovial cultures are negative. Hence, it has been suggested that ReA is developed by
an overstimulated inflammatory response due to bacterial antigens deposited in the joint [4].
However, neither the factors that avoid the complete elimination of these microbial compo-
nents nor the mechanisms favoring the persistent inflammation are clear.
Yersinia enterocolitica (Ye) are Gram-negative bacteria causing food born self-limiting
severe diarrhea, enteritis and mesenteric lymphadenitis [5]. In addition to gastrointestinal
symptoms, the bacteria eventually disseminate systemically to liver and spleen [6]. Ye serotype
O:3 strains are the most frequent cause of human yersiniosis and is a well-established trigger
of ReA [7–9]. Cooperative innate and adaptive immune responses including neutrophils,
macrophages, T cells, and the cytokines interferon (IFN)-γ, tumor necrosis factor (TNF),
interleukin (IL)-12p40 are required to efficiently control Ye infections [10–14]. Although the
pathogenesis of ReA after Ye infection is incompletely understood, it has been reported that
innate immune reactions, that represent early stages of the host’s response to arthritogenic
microbes, may be involved in ReA development [9,15].
TNF is a pleiotropic cytokine considered a major player in the initiation and orchestration
of complex events in inflammation and immunity [16]. Upon stimulation by pathogens or
inflammatory stimuli, macrophages and T and B lymphocytes are the primary sources of TNF
[17]. The biological activities of TNF are mediated by two receptors, TNFRp55 (TNFR1) and
TNFRp75 (TNFR2) [18]. TNFRp75 is restricted to specific cell types, such as immune cells,
neurons and endothelial cells and it is more efficiently activated by transmembrane TNF,
whereas TNFRp55 is ubiquitously expressed and is activated by soluble TNF [16,19]. Further-
more, TNFRp55 is the primary signaling receptor for the majority of the pro-inflammatory
and cytotoxic effects classically attributed to TNF [20]. TNFRp55 is recognized as essential for
the host immune response to Ye [10,21,22]. In previous studies, we have reported a dual role
of TNFRp55: protection from Ye infection in the early immune response, and control of Ye-
induced ReA [22,23]. Hence, we found more severe ReA in TNFRp55-deficient (TNFRp55-/-)
mice compared with their wild-type (WT) counterparts [23].
The subunit p40 is common for the heterodimeric cytokines IL-12 and IL-23 produced by
antigen presenting cells (APCs) in response to certain pathogenic infections. IL-12 promotes
Th1 differentiation and IFN-γ production, and IL-23 alternatively, critically contributes to
Th17 development and function. IL-12/23p40 deregulation has also been implicated in several
autoimmune diseases [24]. Recently, we have reported critical differences of IL-12/23p40 in
joint draining lymph nodes of TNFRp55-/-mice indicating the involvement of IL-12/23p40 in
the generation of augmented production of IFN-γ and IL-17 in Ye-induced ReA under TNFR
p55 deficiency [23,25].
Dendritic cells (DCs) orchestrate immune responses presenting antigens to T lymphocytes
and driving their activation and differentiation to effector T cells [26]. DCs may play an impor-
tant role in the initiation of joint inflammation. Thus, intra-articular injection of collagen-
pulsed pro-inflammatory mature DCs is sufficient to initiate arthritis in mice [27]. Further-
more, DCs are believed to be crucial to the pathogenesis and progression of rheumatoid arthri-
tis [28]. It has been reported that TNFRp55 has paradoxical anti-inflammatory effects on IL-
12/23p40 expression in macrophages and DCs [29]. However, DC involvement in the onset of
Dendritic cell, TNFRp55 and reactive arthritis
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ReA remains unclear. Hence, the purpose of this work is to evaluate whether DCs participate
in the higher amount of IL-12/23p40in the pathophysiological scenario of Ye-induce-
dReAinTNFRp55-/-mice. The results of this study uncover new immunopathogenic mecha-




TNFRp55-/- mice (C57BL/6) were kindly provided by the Max von Pettenkofer Institute,
Munich, Germany. C57BL/6 WT mice were purchased from the Animal Facilities of the
National University of La Plata, Argentina. Breeding colonies were established at the Animal
Facilities of the National University of San Luis, Argentina. Male mice aged between 8 to10
weeks old were used. Mice were kept under specific pathogen-free conditions and provided
with sterile food and water ad libitum.
Ethics statement
Experimental protocols were approved by the Animal Care and Use Committee of the National
University of San Luis, Argentina (Approved protocol number: B 169/13). The condition of the
animals was monitored daily. All efforts were made to minimize suffering or distress.
Bacterial culture and infection
Ye O:3, strain MHC700 (kindly provided by Dr. G. Kapperud, Department of Bacteriology,
Oslo, Norway) was used for infection. Bacteria were cultured as described earlier [21]. Mice
were starved for 3h before and after orogastric infection with 1-5x108yersiniae in 0.2 ml PBS
using a gastric tube. The number of inoculated bacteria was controlled by plating of serial dilu-
tions of the inoculated suspension on Trypticase Soy Agar (TSA) and counting the colony
forming units (CFU) number after incubation at 27˚C for 48h.
In vivo expansion and isolation of DCs
Female TNFRp55-/- or WT mice (4–5 per group) were subcutaneously injected with 5–8 x 106
Flt3L-transfected BL16 melanoma [30] (gently provided by Dr. Gabriel Moro´n, Universidad
Nacional de Co´rdoba, Argentina) in 200 μl saline. When tumors were palpable in both mice
groups, DCs were isolated from the spleen by magnetic beads using MACS anti-mouse CD11c
particles according to manufacturer´s instructions (MiltenyiBiotec Inc. CA, USA). The purity
of DCs CD11c+ (> 95%) was evaluated by flow cytometry.
In vitro cultures
On day 14 after infection, splenocytes were obtained as described previously [23]. Cells were
seeded onto 24-well plates (2 x 106 cells/well) and cultured for 24h at 37˚C under an atmo-
sphere of 5% CO2 in DMEM medium (Life Technologies, CA, USA) supplemented with
10% fetal bovine serum (FBS), 2 mM L-glutamine, 1 mM pyruvate, 100 IU/ml penicillin and
100 μg/ml streptomycin. The cells were stimulated with 1 μg/ml of LPS (Escherichia coli 0111:
B4, Sigma, St Louis, MO, USA) or incubated with medium alone. Culture supernatants were
separated from the cells at different times and stored at -20˚C until cytokine determinations.
After 24h, the cells were harvested and analyzed by flow cytometry.
The JAWS II cell line [31] was gently provided by Dr. Ignacio Cebrian, (Universidad Nacio-
nal de Cuyo, Argentina). These cells were grown in RPMI-1640 media (Life Technologies)
Dendritic cell, TNFRp55 and reactive arthritis
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supplemented with 10% FCS, 2 mM L-glutamine, 1 mM pyruvate, 100 U/ml penicillin,100μg/
ml streptomycin, and 5 ng/ml of recombinant granulocyte/macrophage-colony stimulating
factor (GM-CSF) (Penprotech, Rocky Hill, NJ; US). For stimulation, the JAWS II cells were
treated with1 μg/ml of LPS alone or in combination with 60 ng/ml of hTNF (Miltenyi Biotec
Inc) for 24h.
For the study of MAPK or TNFR involvements, cells were treated with JNK (SP600125),
ERK (PD98059), or p38 MAPK (SB203580) inhibitors (10 μM, all from Calbiochem, San
Diego, CA, US). One hour after treatment with these inhibitors, cells were stimulated with LPS
for 24h. Etanercept (1ng/ml, Enbrel; Pfizer, NY, US) was used for TNF inhibition through
both TNFRp55 and TNFRp75, and CAY10500 (1ng/ml, Santa Cruz, CA, US) for specific inhi-
bition of TNFRp55 during 24h of stimulation with LPS alone or in combination with hTNF.
Supernatants were collected and stored at -20˚C until cytokine determinations.
Cytokine quantification
TNF, IL-12/IL-23p40, IL-17A, IFN-γ and IL-10 levels were determined in cell culture superna-
tants using Enzyme-linked immunosorbent assay (ELISA) kits according to the manufactur-
er’s instructions. TNF, IFN-γ and IL-10 kits were obtained from eBioscience (San Diego, CA,
USA), IL-17A kit from Biolegend (San Diego, CA, USA), and IL-12/23p40 kit from BD Biosci-
ences (San Diego, CA, USA).
Cell preparation and flow cytometry
Antibodies were all purchased from BD Biosciences, unless indicated otherwise. Briefly, cells
were first incubated with anti-mouse CD16/32 (Fc block) for 15 min at 4˚C and then stained
with FITC, PE, APC or PerCP.Cy5.5 conjugates of anti-MHC-II (clone 2G9), anti-CD11c
(clone HL3, Biolegend), anti-F4/80 (clone CI:A3-1), anti-CD80 (clone 16-10A1), anti-CD86
(clone GL1) or anti-CD11b (clone M1/70) for 30 min at 4˚C. For unconjugated anti-CD120a
(TNFRp55, clone 55R-286) or anti-CD120b (TNFRp75, clone TR75-89) antibodies, the cells
were stained a second time with PE-conjugated anti-hamster polyclonal antibody.
For intracellular staining of splenocytes, the cells were stimulated with PMA/ionomycin
(50/750 ng/ml, eBioscience) for 5 h in the presence of GolgiPlug (BD Biosciences). After wash-
ing, cells were stained with anti-MHC-II and anti-CD11c, fixed with 1% paraformaldehyde,
and then a permeabilizing solution BD FACS (BD Biosciences) was applied for intracellular
staining with anti-IL-12/23p40 (clone C15.6).
For detection of Th1 and Th17 lymphocytes, the cells were stained with anti-CD4 (clone
RM4-5) and anti-CD3 (clone 145-2C11), fixed and permeabilized as described above using
anti-IL-17A (clone eBio17B7C15.6, eBioscience) or anti-IFN-γ (clone XMG1.2).
Data were obtained on a FACSCalibur flow cytometer (BD Biosciences) and analyzed with
FlowJo software (Tree Star, Ashland, OR).
Co-culture of DC and T-cells
On day 5 after Ye infection, CD4+ T cells were enriched from the spleen of TNFRp55-/- or WT
mice by magnetic beads using BD IMag anti-mouse CD4 particles according to manufacturer’s
instructions (BD Biosciences). Cell population purity (> 95%) was checked by flow cytometry
analysis.
In vivo expanded and isolated splenic DCs from both mouse groups were in vitro infected
with Ye (moi: 10:1) for 1h, and treated afterwards with gentamicin (100 μg/ml,Life Technolo-
gies) for 24h at 37˚C to kill extracellular bacteria. Then, they were washed and co-cultured
with the WT or TNFRp55-/- CD4+ T-cells at a 1:10 ratio in 96-well culture plates for 5 days at
Dendritic cell, TNFRp55 and reactive arthritis
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37 ˚C under an atmosphere of 5% CO2. The IFN-γ and IL-17A levels were quantified in the
supernatants by ELISA, and Th1 and Th17 cells were analyzed by flow cytometry as described
above.
Statistical analysis
Statistical significance was assessed by Student T-test, one-way analysis of variance (ANOVA)
or two-way ANOVA followed by Tukey or Bonferroni multiple comparison test as appropri-
ate. All experiments were performed at least twice. A p value 0.05 was considered statistically
significant. Data were analyzed using GraphPad Prism 5.0 software (GraphPad Software, La
Jolla, CA, USA).
Results
TNFRp55 deficiency and pro-inflammatory cytokine profile in Ye-infected
spleen cells
TNFRp55-/- mice are susceptible to orogastric Ye O:3 infection [22], and those that survive the
infection develop chronic ReA whose onset is on day 14 [23]. To examine the cytokine profile
of spleen cells of TNFRp55-/- on ReA onset, first we obtained splenocytes from TNFRp55-/- and
WT mice on day 14 after the Ye infection. At the same time, cells from both groups of mice
receiving phosphate-buffered saline (PBS) were used as controls. We assessed the cytokines
secreted by the cells at different times after in vitro stimulation with LPS, and found early TNF
production by cells of infected mice (Fig 1A). Splenocytes from infected TNFRp55-/-mice pro-
duced significantly higher TNF, IL-12/23p40 and IFN-γ levels compared with splenocytes
from infected WT mice (Fig 1A–1C). Although cells from both groups of infected mice
secreted elevated levels of IL-17A, after 12h of LPS-stimulation, supernatants of infected
TNFRp55-/-splenocytes reached the highest IL-17 amounts (Fig 1D).
Interestingly, when we analyzed the levels of the anti-inflammatory cytokine IL-10, a signif-
icant amount of IL-10 was produced by infected splenocytes from both TNFRp55-/- and WT
mice. However, the IL-10 levels appear to be insufficient to control IL-12/23p40 secretion
under TNFRp55 deficiency (Fig 1E and 1B). Higher IL-10 secretion by infected versus unin-
fected WT cells at 24h of stimulation (Fig 1E), seems to efficiently regulate IL-12/23p40 pro-
duction by infected WT splenocytes resulting lower levels than PBS cells of WT mice (Fig 1B).
Thus, the absence of TNFRp55 on spleen cells from infected mice compromises the control of
IL-12/23p40 production under inflammatory stimulation.
TNFRp55-deficient DCs as cellular sources of the IL-12/23p40 subunit
To evaluate the cellular sources of IL-12/23p40 observed after LPS-stimulation, the number
of DCs in spleen cells of TNFRp55-/- and WT mice obtained on day 14 after Ye infection was
assessed. No significant differences were found when the number of splenic DCs was com-
pared between TNFRp55-/- and WT mice (Fig 2A, and S1 Fig). However, the frequency of
splenic TNFRp55-/ -IL-12/23p40+ DCs was significantly higher as compared to WT DCs (Fig
2B and 2C, and S1 Fig). Thus, DCs of TNFRp55-deficient mice are important cellular sources
for the overproduction of IL-12/23p40 detected on Ye-induced ReA onset in TNFRp55-/- mice.
To determine the role of TNFRp55 in DCs on the control of IL-12/23p40, experiments with
isolated DCs were carried out. Although DCs are central APC, they are relatively scarce in vivo
compared with other leukocyte populations. Therefore, since Flt3L has been identified as the
primary differentiation factor for DCs [30,32], we expanded DCs by injection of Flt3L-trans-
fected BL16 melanoma in TNFRp55-/- and WT mice to generate an experimentally useful
Dendritic cell, TNFRp55 and reactive arthritis
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amount of DCs. Then, the activation phenotype of isolated splenicTNFRp55-/- DCs were com-
pared with WT DCs after in vitro infection with Ye O:3. Although probably activated by the
purification process, CD80 and CD86 expressions in Ye-infected TNFRp55-/- DCs were fairly
higher than WT DCs, indicating increased activation in the absence of TNFRp55 (Fig 3A–
3D, and S2 Fig). In addition, the frequency of IL-12/23p40+ DCs isolated from spleen of
TNFRp55-/-mice was again significantly higher compared with those cells of WT mice (Fig 3E).
Thus, deficiency of TNFRp55 signaling increases activation and IL-12/23p40 production in
DCs under in vitro Ye infection.
TNFRp55-/- DCs promoting Th1 and Th17 differentiation of CD4+
lymphocytes
IL-12/23p40 subunit is shared by IL-12 and IL-23, which are cytokines that encourage Th1
and Th17 differentiation, respectively [24]. As described before, high frequency of TNFRp55-/-
IL-12/23p40+ DCs was found (Fig 2B and 2C). As a functional assay for DCs, we then assessed
Th1 and Th17 frequencies in co-culture experiments. Therefore, DCs were isolated from the
spleen of TNFRp55-/- and WT mice and infected in vitro with Ye. These cells were co-cultured
with CD4+lymphocytes purified from TNFRp55-/- or WT mice on day 5 after Ye-infection.
Ye-infected TNFRp55-/- DCs favored the in vitro differentiation of WT CD4+ lymphocytes
to Th1 (Fig 4A and 4B) and Th17 (Fig 5A and 5B) cells more than the Ye-infected WT DCs. In
the same line, we detected significant amounts of IFN-γ (Fig 4C) and IL-17 (Fig 5C) in the
supernatants of co-culture experiments of Ye-infected TNFRp55-/- DCs with WT CD4+ lym-
phocytes. Moreover, Ye-infected TNFRp55-/- DCs increased the frequency of Th1 (Fig 4E, S3
and S4 Figs and S1 Appendix) as well as IFN-γ secretion (Fig 4F, S1 Appendix) of TNFRp55-/-
CD4+ lymphocytes. Conversely, TNFRp55-/- CD4+ lymphocytes did not increase neither on
the frequency of Th17 nor on the production of IL-17 when they were co-cultured with Ye-
Fig 1. Cytokine secretion by LPS-stimulated WT and TNFRp55-/- splenocytes on ReA onset. Splenic cells were obtained from WT and
TNFRp55-/-mice on day 14 after Ye infection (ReA onset), and stimulated in vitro with LPS. Splenocytes from uninfected mice (PBS) were
used as controls. After 3, 12 and 24h of stimulation, supernatants were collected and assayed by ELISA for TNF (A), IL-12/23p40 (B), IFN-γ
(C), IL-17A (D) and IL-10 (E). Values represent the mean ± SEM of quadruplets at each time point of one out of two independent
experiments, with five mice per group. P<0.05;  P<0.01;  P<0.001.
https://doi.org/10.1371/journal.pone.0193573.g001
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infected WT or TNFRp55-/- DCs (Fig 5E and 5F). These results indicate that the absence of
TNFRp55 compromises DCs functions, facilitating the inflammatory Th1 and Th17 profiles,
both previously reported in the joint of TNFRp55-/-mice that developed Ye-Induced ReA [23].
Participation of MAPKs on IL-12/23p40 overproduction by TNFRp55-/-
DCs
Next, we explored the intracellular signal transduction pathways responsible for higher IL-12/
23p40 production by TNFRp55-/- DCs when compared with WT DCs. One of the major
inflammatory signaling pathways from the cell surface to the nucleus is the mitogen-activated
protein kinase (MAPK) signal transduction pathway [33]. MAPKs belong to a large family of
serine/threonine kinases, and include three well-characterized subfamilies: the c-Jun NH2-ter-
minal kinases (JNK), the extracellular signal-regulated kinases (ERK) and the p38 family of
kinases (p38 MAPKs) [34]. Therefore, these pathways were analyzed in splenocytes of unin-
fected (Fig 6A and 6B) and infected WT or TNFRp55-/- mice obtained on day 14 (ReA onset)
(Fig 6C and 6D). These cells were stimulated with LPS in the presence of JNK, ERK or p38
inhibitors. We found that splenocytes from uninfected TNFRp55-/- mice significantly
decreased the IL-12/23p40 production when JNK MAPK was inhibited (Fig 6A and 6B). This
production reached the IL-12/23p40 levels secreted by WT cells at 12h or 24h of LPS-
Fig 2. IL-12/23p40+ dendritic cells in spleen of WT and TNFRp55-/- mice on ReA onset. Splenic cells were obtained
from WT and TNFRp55-/- mice on day 14 after Ye infection (ReA onset). Dendritic cells (DCs) were stained for cell
surface CD11c and MHC-II, and analyzed by flow cytometry. (A) Absolute DC number in the spleen of Ye-infected
WT and TNFRp55-/- mice are presented. Splenic DCs of uninfected (PBS) mice were used as controls. (B)
Representative dot plot showing analysis of IL-12/23p40+ DCs (CD11c+MHC-II+ gate) in splenocytes from control
(PBS), and Ye-infected WT and TNFRp55-/- mice. The cells were stimulated with PMA/Ionomycin and brefeldin for 5
h, and then stained for cell surface CD11c and MHC-II, and intracellular IL-12/23p40, and then analyzed by flow
cytometry. The numbers in the plots indicate the percentages of labeled cells in representative mice. (C) Percentage of
IL-12/23p40+ DCs of the sum of three independent experiments. Each symbol represents an individual mouse;
horizontal lines indicate the mean ± SEM. P<0.001. ns: not significant.
https://doi.org/10.1371/journal.pone.0193573.g002
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Fig 3. Activation profile of and IL-12/23p40 secretion by isolated dendritic cells. Dendritic cells (DCs) were expanded in vivo in WT and TNFRp55-/-
mice. The cells were isolated and infected in vitro with Ye. Representative overlaid flow cytometry histogram analysis showing CD80 (A) and CD86 (C)
expressions of uninfected and Ye-infected splenic DCs. Percentages of DCs CD80+(B) and CD86+ (D), and IL-12/23p40 secretion in the supernatants (E)
expressed as the mean ± SEM of quadruplets of one out of two independent experiments with four mice per group. P<0.05;  P<0.01.
https://doi.org/10.1371/journal.pone.0193573.g003
Fig 4. Th1 differentiation of CD4+ lymphocytes by WT or TNFRp55-/-DCs. Ye-infected splenic DCs of WT or TNFRp55-/-were co-
cultured with purified CD4+ lymphocytes of Ye-infected WT (A), TNFRp55-/-mice (D). The cells were stained with cell surface CD4
and intracellular IFN-γ, and analyzed by flow cytometry. Dot plots from CD3+ CD4+gate, represent a sample of the statistical analysis
shown in B and E (A and D). Percentages of WT CD4+ IFN-γ+ (B) and TNFRp55-/- CD4+ IFN-γ+ (E) T cells. Levels of IFN-γ
measured in culture supernatants by ELISA(C and F). Results are expressed as the mean ± SEM of quadruplets of one out of two
independent experiments with four mice per group. P<0.05;  P<0.01;  P<0.001.
https://doi.org/10.1371/journal.pone.0193573.g004
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stimulation in the presence of JNK or p38 inhibitor, respectively (Fig 6A and 6B). Although
significant reduction in the IL-12/23p40 production by infected TNFRp55-/- splenocytes was
achieved by JNK inhibition, IL-12/23p40 levels were still significantly higher than those
secreted by WT splenocytes (Fig 6C and 6D). In good agreement with uninfected splenocytes,
JNK inhibition also decreased the IL-12/23p40 secretion by splenic WT (Fig 6E) and
TNFRp55-/- (Fig 6F) DCs, reaching similar low levels (Fig 6G). Thus, JNK largely participated
in the overproduction of IL-12/23p40 by TNFRp55-/- DCs, while p38 MAPKs displayed a par-
tial participation.
IL-12/23p40 modulation by TNF in JAWSII cell line
JAWSII is an immortalized DC line derived from the bone marrow of p53-/- mice [31]. We cor-
roborated that these cells express surface markers of DCs, and that after LPS stimulation, they
showed maturation increasing MHC-II and CD86 expressions, and decreasing CD11c marker
(Fig 7A and 7B and S6 Fig). Interestingly, these cells expressed both TNFRp55 and TNFRp75
in moderate levels (Fig 7A and 7B and S6 Fig). In addition, the JAWSII cell line secreted TNF
and IL-12/23p40 in response to LPS (Fig 7C and 7D). Human TNF (hTNF) has previously
demonstrated to bind to mouse TNFRp55 but not to TNFRp75 [35]. Because of this, JAWS II
cells were stimulated with LPS in the presence of hTNF, and a significant reduction of IL-12/
23p40 secretion was observed (Fig 7D). Moreover, in JAWS II cell line the IL-12/23p40 pro-
duction decreased significantly by p38, ERK and mainly JNK inhibitions (Fig 7E). As a conse-
quence, these results suggest that JAWSII cells are suitable as a model to gain an insight into
the mechanisms underlying the regulatory effect of TNF through TNFRp55 on IL-12/23p40
secretion, mirroring the results obtained in splenic DCs.
Fig 5. Th17 differentiation of CD4+ lymphocytes by WT or TNFRp55-/- DCs. Ye-infected splenic DCs of WT or TNFRp55-/-were
co-cultured with purified CD4+ lymphocytes of Ye-infected WT (A) or TNFRp55-/-mice (D) as described in methods. The cells were
stained with cell surface CD4 and intracellular IL-17, and analyzed by flow cytometry. Dot plots from CD3+ CD4+ gate, represent a
sample of the statistical analysis shown in B and E (A and D). Percentages of WT CD4+ IL-17A+ (B) and TNFRp55-/- CD4+ IL-17A+
(E) T cells. Levels of IL-17A measured in culture supernatants by ELISA (C and F). Results are expressed as the mean ± SEM of
quadruplets of one out of two independent experiments with four mice per group. P<0.05;  P<0.001. ns: not significant.
https://doi.org/10.1371/journal.pone.0193573.g005
Dendritic cell, TNFRp55 and reactive arthritis
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Regulation of IL-12/23p40 production by TNFRp55 signaling and role of
IL-10
In order to know how TNFRp55 signaling modulates IL-12/23p40 production, we isolated
splenic WT or TNFRp55-/- DCs, and stimulated with LPS in presence and absence of TNF or
TNF inhibitors. We used Etanercept, which is a fusion protein consisting of the Fc domain
of human IgG1 fused to a dimmer of the extracellular ligand-binding domain of human
TNFRp75. It binds with high affinity to both soluble and transmembrane forms of TNF [36].
First, hTNF showed a regulatory effect on IL-12/23p40 secretion by LPS-stimulated WT DCs,
and this effect was lost in TNFRp55-/- DCs (Fig 8A and 8B). Moreover, Etanercept decreased
IL-12/23p40 secretion in both LPS-stimulated WT and TNFRp55-/-DCs (Fig 8A and 8B). Fur-
thermore, this TNF inhibitor did not change the TNF-mediated regulatory effect on IL-12/
Fig 6. Participation of MAPKs on IL-12/23p40 overproduction by dendritic cells. Splenic cells were obtained from
uninfected (A and B) and Ye-infected WT and TNFRp55-/- mice (on ReA onset) (C and D), and stimulated in vitro
with LPS in the presence of the indicated MAPK inhibitors. After 12 and 24h, supernatants were collected from the cell
culture, and assayed by ELISA for IL-12/23p40. The same experimental scheme was performed with in vivo expanded
and isolated WT and TNFRp55-/- DCs. After 24h, IL-12/23p40 was assessed in the 24h-supernatants of WT (E) and
TNFRp55-/- (F) DCs. A comparison of IL-12/23p40 levels in the supernatants of WT versus TNFRp55-/- DCs was
performed (G). Results are expressed as the mean ± SEM of quadruplets of one out of two independent experiments
with four mice per group.  P<0.01;  P<0.001. ns: not significant.
https://doi.org/10.1371/journal.pone.0193573.g006
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Fig 7. Phenotypical and functional characterization of JAWS II cell line. Representative overlaid flow cytometry
histogram (A) and percentage (B) analysis, showing dendritic cell surface markers and TNF receptors in JAWS II cell
line after 24h of stimulation with LPS. Unstimulated cells (basal) were used as controls. The levels of TNF (C) were
assessed in the supernatants by ELISA. JAWS II cells were stimulated with LPS alone or in combination with human
TNF (D), or in the presence of MAPK inhibitors (E). IL-12/23p40 secretion was analyzed in these supernatants. The
results represent the mean ± SEM of quadruplets of one out of two independent experiments. P<0.05;  P<0.01;
 P<0.001.
https://doi.org/10.1371/journal.pone.0193573.g007
Fig 8. Contribution of TNFRp75 and TNFRp55 to IL-12/23p40 production by WT and TNFRp55-/- dendritic cells.
Isolated WT (A, C, E and G) and TNFRp55-/- (B, D, F and H) DCs were stimulated with LPS alone or in the presence of
Etanercept (A, B, E, F) that inhibits both TNFRp75 and TNFRp55; or CAY10500 (C, D, G and H) that blocks
specifically TNFRp55. After 24h, the supernatants were collected and assayed by ELISA for IL-12/23p40 (A-D), and IL-
10 (E-H). Results are expressed as the mean ± SEM of quadruplets of one out of two independent experiments.
P<0.05;  P<0.01. ns: not significant.
https://doi.org/10.1371/journal.pone.0193573.g008
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23p40 in WT DCs (Fig 8A). These results suggested a TNFRp75-depending IL-12/23p40 pro-
duction by DCs, and a regulatory function of the TNFRp55 pathway.
To confirm these findings, DCs were stimulated with LPS in presence of CAY10500 inhibi-
tor, which blocks specifically the TNF-TNFRp55 pathway[37]. In addition, we analyzed IL-10
levels in the supernatants, since this cytokine is one of the most important and known nega-
tive-regulators of IL-12/23p40 secretion [38]. As expected, CAY10500 inhibitor did not affect
IL-12/23p40 induction by LPS. However, this TNFRp55-specific inhibitor blocked the regula-
tory effect of hTNFin WT DCs (Fig 8C). This result mirrored the effect of hTNF on LPS-stim-
ulated TNFRp55-/- DCs (Fig 8D). Conversely, IL-10 amount was not modified by Etanercept in
LPS-stimulated WT as well as TNFRp55-/- DCs (Fig 8E and 8F). However, IL-10 levels resulted
significantly reduced by the CAY10500 inhibitor in hTNF/LPS-stimulated WT DCs, but not
in TNFRp55-/- DCs (Fig 8G and 8H). These data indicate that IL-10 seems to mediate the regu-
latory effect of the TNFRp55 pathway on IL-12/23p40 secretion by LPS-stimulated DCs.
Discussion
DCs are well established as the most effective among the APC [32]. Strong efforts were made
to elucidate the function of DCs in arthropathies such as rheumatoid arthritis [28], but little
is known about their roles in ReA. In previous works, we demonstrated chronic ReA in
TNFRp55-/- mice after Ye infection [22], and pro-inflammatory Th1 and Th17 cells acting in
concert to sustain this arthritogenic processes [23]. In line with this, an increased amount of
IL-12/23p40, IL-12p70 and IL-23 in the joint draining lymph nodes provided a rational expla-
nation for T helper deviation to Th1/Th17 responses [23,25]. Because of DCs ability to guide
the Th differentiation by secretion of specific cytokines, this study was aimed to investigate the
role of DCs on IL-12/23p40 overproduction inYe-induced ReA developed in TNFRp55-/- mice.
TNF is a pleiotropic cytokine with a diverse range of biological activities. Further evidence
points to the pro-inflammatory effects of TNF. Thus, this cytokine has been placed at the cen-
ter of the complex scenario of the pathogenesis of immune-mediated inflammatory diseases,
such as rheumatoid arthritis, ankylosing spondylitis and Crohn’s disease. It has also been con-
firmed by the efficacy of anti-TNF treatments [39–41].
However, there have been several investigations suggesting an anti-inflammatory role of
TNF in limiting inflammatory processes induced by in vivo infections as well as by autoim-
mune diseases [42,43]. In addition, exacerbations of autoimmune diseases under anti-TNF
therapy were attributed to anti-inflammatory effects of TNF [44]. Here, we found that splenic
cells obtained from TNFRp55-/- mice on ReA onset were unable to control secretions of pro-
inflammatory cytokines in response to LPS. These findings support previous in vitro studies
that recognized TNFRp55 as the main receptor involved in IL-12/23p40 regulation [29,39]. As
reported by other authors, we detected that WT splenocytes obtained under inflammatory
conditions were more susceptible to IL-12/23p40 regulation than those obtained under resting
conditions [29]. In line with the known function of IL-12 to mediate Th1 response, we found a
clear association between the significant increases of IL-12/23p40 and IFN-γproductions by
TNFRp55-/-splenocytes [45]. In contrast, we did not detect direct connection between IL-12/
23p40 and IL-17 productions. Moreover, a considerable IL-17 amount was secreted by infected
WT and TNFRp55-/- splenocytes in response to LPS. These findings might be due to the fact
that Th17 differentiation is influenced not only by IL-23, but also by TGF-ß, IL-6 and IL-21
[46].
Evidences in animal models implicate DCs in the SpA pathogenesis, a group of inflamma-
tory arthropathies that include ReA [47]. It has been demonstrated that IL-23 mediates enthe-
sitis, a hallmark of SpA-like disease, and that IL-23 was produced by CD11b+ population,
Dendritic cell, TNFRp55 and reactive arthritis
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which included macrophages and DCs [47]. In this study, we detected that TNFRp55 defi-
ciency did not affect DC number in spleen, but impacted on the frequency of IL-12/
23p40+DCs. These results indicated that DCs seem to be the cellular source of the IL-12/23p40
overproduction by TNFRp55-/-splenocytes. After in vivo expansion, we showed that isolated
TNFRp55-/- DCs secreted a larger amount of IL-12/23p40, and they could lead lymphocytes to
Th1 and Th17 responses. Sing et al found higher levels of IL-17, IFN-γ and IL-12p40 in syno-
vial fluids of patients with ReA/uSpA as compared to those with osteoarthritis [48]. Further-
more, it has been reported that Th17 are expanded and induced by DCs in SpA-prone
HLA-B27-transgenic rats [49]. Therefore, IL-12/23p40 overproduction might be a mechanism
used by DCs to drive Ye-induced ReA in TNFRp55-/- mice.
Since it has been demonstrated that IL-12 is induced by LPS among other TLR ligands, we
used LPS as TLR4 ligand for stimulating IL-12/23p40 in DCs. Furthermore, LPS represents a
component of Gram-negative bacteria that mirrors in vitro a molecule present during Yersinia
infection in our in vivo ReA model. Moreover, it has been also demonstrated that TNF is a
potent regulator of IL-12p40 expression through TLR signaling pathways, including TLR4
[29,39]. In addition, the MAPKs are central downstream molecules in shuttling the signal of
pro-inflammatory cytokines [50]. In our study, a considerable reduction on IL-12/23p40 pro-
duction was detected in LPS-stimulated splenocytes and isolated DCs treated with JNK inhibi-
tor. These findings indicate that JNK might mediate the IL-12/23p40 overproduction under
TNFRp55deficiency. Indeed, JNK inhibition resulted in inhibition of TLR2-mediated IL-12/
23p40 production [51]. In addition, it has been reported that JNK activates AP-1 transcription
factor, which has a dual effect on IL-12/23p40 production, inducing [52] or regulating [53]
mRNA transcription of this cytokine subunit. Here, the regulatory effect of TNF on IL-12/
23p40 and the role of JNK on IL-12/23p40 were confirmed in the JAWS II cell line. Since a
long time was necessary to obtain expanded DCs, we consider that this cell line will help in
reducing time to uncover further downstream signaling involved in IL-12/23p40 regulation by
TNFRp55.
The TNFRp55 signaling pathway includes the death domain-containing proteins (TNFR1,
TRADD, RIP and FADD), leading to activation of signaling cascades that mediate JNK activa-
tion, and nuclear factor kappa-B (NF-κB) activation [20]. In addition, TLR4 plays important
roles in inflammation by regulating the activity of NF-κB [54,55]. It has been shown that
TNFRp55 and TLR-4 upstream signaling components are mostly receptor-specific, but the
principles of signaling are similar, involving the recruitment of specific adaptor proteins and
the activation of kinase cascades in which protein-protein interactions are controlled by poly-
ubiquitination [54]. Moreover, these pathways include highly regulated proteins involving
negative regulators that participate to induce an anti-inflammation response to a coordinated
control feedback [54,55]. In this study, it was observed that Etanercept reduced IL-12/23p40
secretion in both LPS-stimulated WT and TNFRp55-/- DCs, suggesting that TNFRp75, but not
TNFRp55, participates in IL-12/23p40 production in our experimental conditions. In contrast,
a specific inhibition of TNFRp55 signaling avoided the regulatory effect of TNF on IL-12/
23p40 production by LPS-stimulated WT DCs. Therefore, it is unlikely that TNFRp75 signal
plays a function in the anti-inflammatory effect of TNF. Rather, the data strongly support the
role of the TNFRp55 pathway in keeping IL-12/23p40 under control. In addition, the results in
infected TNFRp55-/- splenocytes and LPS-stimulated DCs supported the involvement of IL-10
as a well-studied negative regulator of IL-12 secretion [37]. Furthermore, IL-10 regulates IL-
12/23p40 production by transcriptional and epigenetic mechanisms [38]. However, we could
not exclude other IL-10-independent mechanisms participating in the regulatory effect of
TNF through TNFRp55, as suggested by other reports [44]. Because of this, we propose a
model of DC role mediated by TNFRp55, in the control of Ye-induced ReA (Fig 9). Whether
Dendritic cell, TNFRp55 and reactive arthritis
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TNF/TNFRp55 pathway may interrupt directly TLR4 signaling has not been explored in our
study. A previous report identified candidate proteins associated with a cross-talk between
TNFRp55 and TLR4 signaling pathways [54], and indicated A20 as a negative regulator of the
core crosstalk element TNFR-associated factor 6 (TRAF6), which has been demonstrated to be
a main target of many regulatory molecules of TLR4 signaling [55].
Further studies will elucidate the intermediate molecules in the cross-talk among TNFRp55,
IL-12/23p40 and IL-10 in DCs during the immune response against bacterial antigens.
In summary, we have shown that DCs are essential cells in the immunopathogenic scenario
of Ye-induce ReA in TNFRp55-/- mice. One mechanism of their participation is the overpro-
duction of IL-12/23p40, leading to Th1 and Th17 programs. An anti-inflammatory function of
the TNF/TNFRp55 pathway in DCs might contribute to the protection against ReA during the
resolution of bacterial infection. Targeting this regulatory circuit might represent an option to
control chronic arthritis.
Supporting information
S1 Appendix. Explanation of the two distinct CD3+CD4+ populations observed in S3 Fig.
CD4 has an important role in Th response to antigen in the context of MHC-II molecules, ini-
tiating the events that lead to activation of these cells [Ravichandran KS et al, Curr Top Micro-
biol Immunol. 1996;205:47–62]. In the co-culture experiments, we detected two distinct
Fig 9. Proposal model of the participation of DCs controlling IL-12/23p40 through TNFRp55 and TNFRp75
under bacterial antigen stimulation. TNF through TNFRp75 triggers IL-12/23p40 secretion by DCs. This IL-12/
23p40 production is controlled by TNF/TNFRp55 pathway involving IL-10 and other unknown mechanisms. In the
absence of the regulatory TNF/TNFRp55 circuit, DCs increase IL-12/23p40 secretion, driving the adaptive response to
chronic Th1 and Th17 programs. Black spots represent inflammatory cytokines, and grey spots represent regulatory
cytokines.
https://doi.org/10.1371/journal.pone.0193573.g009
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populations of CD4+ T cells (S3 Fig), one of them with lower CD4 expression. It has been dem-
onstrated that under in vitro continuous stimulation, CD4 can be modulated on T cells [Grish-
kan IV et al, Cell Immunol. 2013; 284: 68–74]. Accordingly, in our work, CD4+ T cells received
long in vivo and in vitro stimulation since they were obtained from the spleen of TNFRp55-/- or
WT mice on day 5 after Ye infection, and after enriching by magnetic beads, they were co-cul-
tured with Ye-infected DCs for 5 days. During this time, we detected cellular proliferation of
CD4+ T cells (S4 Fig). In accordance with the population that expressed lower levels of CD4
(gate 1 of S5 Fig), the percentage of proliferating cells was about 10% (S4 Fig), suggesting that
these cells correspond to the CD4+ cells that expressed lower CD4. In addition, we observed
that both CD4+ T cells populations displayed IFN-γ or IL-17 production, and they mirrored
the differences observed in all CD4+ T cells (Figs 4 and 5 and S5 Fig). Therefore, we present
in Figs 4 and 5 of the main manuscript the results of total CD4+ T cells that summery the
response of the two CD4+ populations.
(DOCX)
S1 Fig. Gating strategy for flow cytometry analysis of dendritic cells, and after intracellular
IL-12/23p40 staining. A. In this sample gating, cells were first gated for leucocytes (SSC-H vs
FSC-H) and then for dendritic cells (DCs) (CD11c+MHC-II+ gate). B. In this sample gating,
cells were first analyzed as explained above and then DCs were further analyzed to measure
IL-12/23p40 expression. Fluorescence-minus-one (FMO) control was included to define the
selected population.
(TIF)
S2 Fig. Gating strategy for flow cytometry analysis of isolated dendritic cells after in vivo
expansion. Splenic CD11c+ cells were isolated by using anti-mouse CD11c magnetic beads. In
this sample gating the isolated cells were gated for CD11c expression (SSC-H vs CD11c), and
then for dendritic cells (DCs) (CD11c+MHC-II+ gate). CD80 and CD86 surface expression
was then determined, and histogram analyses are shown. Fluorescence-minus-one (FMO)
control (grey histogram) was included to define the selected population.
(TIF)
S3 Fig. Gating strategy for flow cytometry analysis of CD4+ T cells used in co-culture
assays. Splenic CD4+ cells were isolated by using anti-mouse CD4 magnetic beads. In this
sample gating, cells were first gated for leucocytes (SSC-H vs FSC-H) and then for CD4+ T
lymphocytes (CD3+ CD4+). Finally, the cells were further analyzed to measure IFN-γ or IL-
17A expression. Fluorescence-minus-one (FMO) controls were used to define the selected
population for each cytokine expression.
(TIF)
S4 Fig. Proliferation of CD4+ T cells. CFSE-labeled WT or TNFRp55-/- CD4+ T cells were co-
cultivated at a 1:10 ratio with unlabeled WT or TNFRp55-/- DCs (in Ye-infected or uninfected
conditions). On day 5, the cells were collected and immediately analyzed using the FACSCali-
bur cytometer. A and C. Representative overlaid flow cytometry histogram analysis showing
CFSE expression on lymphocytes based upon forward and side light scatter profiles. Numbers
indicate percentages of proliferating CD4+cells. Unproliferating cells (grey histogram) were
used to define the selected population. Percentages of WT CFSE+ CD4+ T cells (B) and
TNFRp55-/- CFSE+ CD4+ T cells (D). ns: not significant.
(TIF)
S5 Fig. Gating strategy for flow cytometry analysis of IFN-γ or IL-17A expression by the
two populations of CD4+ T cells in co-culture assays. A and F. In this sample gating, cells
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were first gated for leucocytes (SSC-H vs FSC-H) as showed in S3 Fig, then for CD4+ T lym-
phocytes (CD3+ CD4+), and finally two distinct populations were selected (gate 1 and gate 2).
The cells of each gate were further analyzed to measure IFN-γ (A) or IL-17A (F) expression.
Fluorescence-minus-one (FMO) controls were used to define the selected population for each
cytokine expression. Percentages of WT CD4+ IFN-γ+ (B and C) and TNFRp55-/- CD4+ IFN-
γ+ (D and E) T cells. Percentages of WT CD4+ IL-17A+ (G and H) and TNFRp55-/- CD4+ IL-
17A+ (I and J) T cells.  P<0.01;  P<0.001. ns: not significant.
(TIF)
S6 Fig. Gating strategy for flow cytometry analysis of JAWSII cell line. In this sample gat-
ing, cells were initially gated on SSC/FSC and then for live cells (7AAD negative). Finally,
these cells were further analyzed to determine F4/80, CD11b, CD11c, MHC-II, CD80, CD86,
TNFRp55 and TNFRp75 surface expression. Fluorescence-minus-one (FMO) control (grey
histogram) was included to define the selected population in each histogram analysis.
(TIF)
Acknowledgments
We acknowledge Gabinete de Asesoramiento en Escritura Cientı´fica en Ingle´s (GAECI), Uni-
versidad Nacional de San Luis for language improvement of our manuscript.
Author Contributions
Conceptualization: Andrea Constanza Mayordomo, Marı´a Silvia Di Genaro.
Data curation: Andrea Constanza Mayordomo, Juan Eduardo Silva, Jose´ Luis Arias.
Formal analysis: Andrea Constanza Mayordomo, Juan Eduardo Silva, Carolina Virginia Gor-
lino, Walter Bero´n.
Funding acquisition: Marı´a Silvia Di Genaro.
Investigation: Andrea Constanza Mayordomo, Juan Eduardo Silva, Carolina Virginia Gor-
lino, Jose´ Luis Arias, Walter Bero´n, Marı´a Silvia Di Genaro.
Methodology: Andrea Constanza Mayordomo, Juan Eduardo Silva, Carolina Virginia Gor-
lino, Jose´ Luis Arias.
Project administration: Marı´a Silvia Di Genaro.
Supervision: Marı´a Silvia Di Genaro.
Writing – original draft: Marı´a Silvia Di Genaro.
Writing – review & editing: Andrea Constanza Mayordomo, Juan Eduardo Silva, Carolina
Virginia Gorlino, Jose´ Luis Arias, Walter Bero´n, Marı´a Silvia Di Genaro.
References
1. Selmi C, Gershwin ME. Diagnosis and classification of reactive arthritis. Autoimmun Rev. 2014; 13(4–
5):546–549. https://doi.org/10.1016/j.autrev.2014.01.005 PMID: 24418301
2. Leirisalo-Repo M. Reactive arthritis. Scand J Rheumatol. 2005; 34(4):251–259. https://doi.org/10.
1080/03009740500202540 PMID: 16195157
3. Kvien TK, Glennås A, Melby K, Granfors K, Andrup O, Karstensen B, et al. Reactive arthritis: incidence,
triggering agents and clinical presentation. J Rheumatol. 1994; 21(1):115–122. PMID: 8151565
Dendritic cell, TNFRp55 and reactive arthritis
PLOS ONE | https://doi.org/10.1371/journal.pone.0193573 March 1, 2018 16 / 19
4. Carter JD, Gerard HC, Espinoza LR, Ricca LR, Valeriano J, Snelgrove J, et al. Chlamydiae as etiologic
agents in chronic undifferentiated spondylarthritis. Arthritis Rheum. 2009; 60(5):1311–1316. https://doi.
org/10.1002/art.24431 PMID: 19404948
5. Bottone EJ. Yersinia enterocolitica: overview and epidemiologic correlates. Microbes Infect. 1999; 1
(4):323–333. PMID: 10602666
6. Autenrieth IB, Firsching R. Penetration of M cells and destruction of Peyer’s patches by Yersinia entero-
colitica: an ultrastructural and histological study. J Med Microbiol. 1996; 44(4):285–294. https://doi.org/
10.1099/00222615-44-4-285 PMID: 8606357
7. Uliczka F, Pisano F, Schaake J, Stolz T, Rohde M, Fruth A, et al. Unique cell adhesion and invasion
properties of Yersinia enterocolitica O:3, the most frequent cause of human Yersiniosis. PLoS Pathog
2011; 7(7):e1002117. https://doi.org/10.1371/journal.ppat.1002117 PMID: 21750675
8. Granfors K, Merilahti-Palo R, Luukkainen R, Mo¨tto¨nen T, Lahesmaa R, Probst P, et al. Persistence of
Yersinia antigens in peripheral blood cells from patients with Yersinia enterocolitica O:3 infection with or
without reactive arthritis. Arthritis Rheum. 1998; 41(5):855–862. https://doi.org/10.1002/1529-0131
(199805)41:5<855::AID-ART12>3.0.CO;2-J PMID: 9588737
9. Va¨lima¨ki E, Aittoma¨ki S, Karenko L, Kantonen J, Pettersson T, Turunen U, et al. Normal inflammasome
activation and low production of IL-23 by monocyte derived macrophages from subjects with a history of
reactive arthritis. Scand J Rheumatol. 2013; 42(4):294–298. https://doi.org/10.3109/03009742.2012.
754940 PMID: 23425136
10. Autenrieth IB, Kempf V, Sprinz T, Preger S, Schnell A. Defense mechanisms in Peyer’s patches and
mesenteric lymph nodes against Yersinia enterocolitica involve integrins and cytokines. Infect Immun.
1996; 64(4):1357–1368. PMID: 8606101
11. Conlan JW. Critical roles of neutrophils in host defense against experimental systemic infections of
mice by Listeria monocytogenes, Salmonella typhimurium, and Yersinia enterocolitica. Infect Immun.
1997; 65(2):630–635 PMID: 9009323
12. Autenrieth IB, Tingle A, Reske-Kunz A, Heesemann J. T lymphocytes mediate protection against Yersi-
nia enterocolitica in mice: characterization of murine T-cell clones specific for Y. enterocolitica. Infect
Immun. 1992; 60(3):1140–1149. PMID: 1541529
13. Autenrieth IB, Hantschmann P, Heymer B, Heesemann J. Immunohistological characterization of the
cellular immune response against Yersinia enterocolitica in mice: Evidence for the involvement of T lym-
phocytes. Immunobiology 1993; 187(1–2):1–16. https://doi.org/10.1016/S0171-2985(11)80241-X
PMID: 8505058
14. Bohn E, Schmitt E, Bielfeldt C, Noll A, Schulte R, Autenrieth IB. Ambiguous role of interleukin-12 in Yer-
sinia enterocolitica infection in susceptible and resistant mouse strains. Infect Immun. 1998; 66
(5):2213–2220. PMID: 9573110
15. Inman RD. Innate immunity of spondyloarthritis: the role of Toll like receptors. Adv Exp Med Biol. 2009;
649:300–309. PMID: 19731639
16. Kalliolias GD, Ivashkiv LB. TNF biology, pathogenic mechanisms and emerging therapeutic strategies.
Nat Rev Rheumatol. 2016; 12(1):49–62. https://doi.org/10.1038/nrrheum.2015.169 PMID: 26656660
17. Chen X, Oppenheim JJ. Contrasting effects of TNF and anti-TNF on the activation of effector T cells
and regulatory T cells in autoimmunity. FEBS Lett 2011; 585(23):3611–3618. https://doi.org/10.1016/j.
febslet.2011.04.025 PMID: 21513711
18. Aggarwal BB. Signalling pathways of the TNF superfamily: a double-edged sword. Nat Rev Immunol.
2003; 3(9):745–756. https://doi.org/10.1038/nri1184 PMID: 12949498
19. Grell M, Douni E, Wajant H, Lo¨hden M, Clauss M, Maxeiner B, et al. The transmembrane form of tumor
necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor. Cell 1995; 83
(5):793–802. PMID: 8521496
20. Chen G, Goeddel DV.TNF-R1 signaling: a beautiful pathway. Science 2002; 296(5573):1634–1635.
https://doi.org/10.1126/science.1071924 PMID: 12040173
21. Di Genaro MS, Waidmann M, Kramer U, Hitziger N, Bohn E, Autenrieth IB. Attenuated Yersinia entero-
colitica mutant strains exhibit differential virulence in cytokine-deficient mice: implications for the devel-
opment of novel live carrier vaccines. Infect Immun. 2003; 71(4):1804–1812 https://doi.org/10.1128/IAI.
71.4.1804-1812.2003 PMID: 12654794
22. Di Genaro MS, Cargnelutti DE, Elic¸abe JR, Lacoste MG, Valdez S, Go´mez N, de Guzma´n AM. Role of
TNFRp55 in Yersinia enterocolitica O:3-induced arthritis: triggering bacterial antigens and articular
immune response. Rheumatology (Oxford) 2007; 46(4):590–596.
23. Elic¸abe RJ, Cargnelutti E, Serer MI, Stege PW, Valdez SR, Toscano MA, Rabinovich GA, Di Genaro
MS. Lack of TNFR p55 results in heightened expression of IFN-γ and IL-17 during the development of
Dendritic cell, TNFRp55 and reactive arthritis
PLOS ONE | https://doi.org/10.1371/journal.pone.0193573 March 1, 2018 17 / 19
reactive arthritis. J Immunol. 2010; 185(7):4485–4495. https://doi.org/10.4049/jimmunol.0902245
PMID: 20810989
24. Teng MW, Bowman EP, McElwee JJ, Smyth MJ, Casanova JL, Cooper AM, et al. IL-12 and IL-23 cyto-
kines: from discovery to targeted therapies for immune-mediated inflammatory diseases. Nat Med.
2015; 21(7):719–729. https://doi.org/10.1038/nm.3895 PMID: 26121196
25. Cargnelutti E, Arias JL, Valdez SR, Rabinovich GA, Di Genaro MS. TNFRp55 controls regulatory T cell
responses in Yersinia-induced reactive arthritis. Immunol Cell Biol. 2013; 91(2):159–166. https://doi.
org/10.1038/icb.2012.65 PMID: 23207279
26. Diebold SS. Determination of T-cell fate by dendritic cells. Immunol Cell Biol. 2008; 86(5):389–397.
https://doi.org/10.1038/icb.2008.26 PMID: 18382438
27. Leung BP, Conacher M, Hunter D, McInnes IB, Liew FY, Brewer JM. A novel dendritic cell-induced
model of erosive inflammatory arthritis: distinct roles for dendritic cells in T cell activation and induction
of local inflammation. J Immunol. 2002; 169(12):7071–7077. PMID: 12471143
28. Yu MB, Langridge WHR. The function of myeloid dendritic cells in rheumatoid arthritis. Rheumatol Int.
2017; 37(7):1043–1051. https://doi.org/10.1007/s00296-017-3671-z PMID: 28236220
29. Zakharova M, Ziegler HK. Paradoxical anti-inflammatory actions of TNF-alpha: inhibition of IL-12 and
IL-23 via TNF receptor 1 in macrophages and dendritic cells. J Immunol. 2005; 175(8):5024–5033.
PMID: 16210605
30. Pham NL, Badovinac VP, Harty JT. A default pathway of memory CD8 T cell differentiation after den-
dritic cell immunization is deflected by encounter with inflammatory cytokines during antigen-driven pro-
liferation. J Immunol. 2009; 183 (4):2337–2348. https://doi.org/10.4049/jimmunol.0901203 PMID:
19635915
31. Jiang X, Shen C, Rey-Ladino J, Yu H, Brunham RC. Characterization of murine dendritic cell line Jaws
II and primary bone marrow-derived dendritic cells in Chlamydia muridarum antigen presentation and
induction of protective immunity. Infect Immun. 2008; 76(6):2392–2401. https://doi.org/10.1128/IAI.
01584-07 PMID: 18362126
32. Merad M, Manz MG. Dendritic cell homeostasis. Blood 2009; 113(15):3418–3427. https://doi.org/10.
1182/blood-2008-12-180646 PMID: 19176316
33. Dong C, Davis R, Flavell R. MAP kinases in immune response. Annu Rev Immunol. 2002; 20:55–72.
https://doi.org/10.1146/annurev.immunol.20.091301.131133 PMID: 11861597
34. Johnson GL, Lapadat R. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38
protein kinases. Science 2002; 298(5600):1911–1912. https://doi.org/10.1126/science.1072682 PMID:
12471242
35. Zhang Y, Mukaida N, Wang JB, Harada A, Akiyama M, Matsushima K. Induction of dendritic cell differ-
entiation by granulocyte-macrophage colony-stimulating factor, stem cell factor, and tumor necrosis fac-
tor α in vitro from lineage phenotypes-negative c-kit+ murine hematopoietic progenitor cells. Blood
1997; 90(12):4842–4853. PMID: 9389701
36. Lis K, Olga Kuzawińska O, Bałkowiec-Iskra E. Tumor necrosis factor inhibitors—state of knowledge.
Arch Med Sci. 2014; 10(6):1175–1185. PMID: 25624856
37. He MM, Smith AS, Oslob JD, Flanagan WM, Braisted AC, Whitty A, et al. Small-molecule inhibition of
TNF-alpha. Science 2005; 310(5750):1022–1025. https://doi.org/10.1126/science.1116304 PMID:
16284179
38. Kobayashi T Matsuoka K, Sheikh SZ, Russo SM, Mishima Y, Collins C, et al. IL-10 regulates Il12b
expression via histone deacetylation: implications for intestinal macrophage homeostasis. J Immunol.
2012; 189(4):1792–1799. https://doi.org/10.4049/jimmunol.1200042 PMID: 22786766
39. Ma X. TNF-α and IL-12: a balancing act in macrophage functioning. Microbes Infect. 2001; 3(2):121–
129. PMID: 11251298
40. Blandizzi C, Gionchetti P, Armuzzi A, Caporali R, Chimenti S, Cimaz R, et al. The role of tumour necro-
sis factor in the pathogenesis of immune-mediated diseases. Int J Immunopathol Pharmacol. 2014; 27
(1Suppl):1–10.
41. Mitoma H, Horiuchi T, Tsukamoto H, Ueda N. Molecular mechanisms of action of anti-TNF-α agents-
comparison among therapeutic TNF-α antagonists. Cytokine 2016; S1043-4666(16):30468–30469.
42. Vieira LQ, Goldschmidt M, Nashleanas M, Pfeffer K, Mak T, Scott P. Mice lacking the TNF receptor p55
fail to resolve lesions caused by infection with Leishmania major, but control parasite replication. J
Immunol. 1996; 157(2):827–835. PMID: 8752935
43. Liu J, Marino MW, Wong G, Grail D, Dunn A, Bettadapura J, Slavin AJ, Old L, Bernard CC. TNF is a
potent anti-inflammatory cytokine in autoimmune mediated demyelination. Nat Med. 1998; 4(1):78–83.
PMID: 9427610
Dendritic cell, TNFRp55 and reactive arthritis
PLOS ONE | https://doi.org/10.1371/journal.pone.0193573 March 1, 2018 18 / 19
44. Williams-Skipp C, Raman T, Valuck RJ, Watkins H, Palmer BE, Scheinman. Unmasking of a protective
tumor necrosis factor receptor I-mediated signal in collagen-induced arthritis model. Arthritis Rheum.
2009; 60(2):408–418. https://doi.org/10.1002/art.24260 PMID: 19180511
45. Ma X, Chow JM, Gri G, Carra G, Gerosa F, Wolf SF, Dzialo R, Trinchieri G. The interleukin 12p40 gene
promoter is primed by interferon gamma in monocytic cells. J Exp Med. 1996; 183(1):147–157. PMID:
8551218
46. Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M, et al. Reciprocal developmental pathways for
the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006; 441(7090):235–238.
https://doi.org/10.1038/nature04753 PMID: 16648838
47. Wright P, Utriainen L, Milling S. Dendritic cells and regulatory T cells in spondyloarthritis. Curr Opin
Rheumatol. 2013, 25(4):440–447. https://doi.org/10.1097/BOR.0b013e32836202dc PMID: 23719362
48. Singh R, Aggarwal A, Misra R. Th1/Th17 cytokine profiles in patients with reactive arthritis/undifferenti-
ated. J Rheumatol. 2007; 34(11):2285–2290. PMID: 17937463
49. Glatigny S, Fert I, Blaton MA, Lories RJ, Araujo LM, Chiocchia G, et al. Proinflammatory Th17 cells are
expanded and induced by dendritic cells in spondylarthritis-prone HLA-B27-transgenic rats. Arthritis
Rheum. 2012; 64(1):110–20. https://doi.org/10.1002/art.33321 PMID: 21905004
50. Quan JH, Chu JQ, Kwon J, Choi IW, Ismail HA, Zhou W, et al. Intracellular networks of the PI3K/AKT
and MAPK pathways for regulating Toxoplasma gondii-induced IL-23 and IL-12 production in human
THP-1 cells. PLoS One 2015; 10(11): e0141550 https://doi.org/10.1371/journal.pone.0141550 PMID:
26528819
51. Wang H, Brown J, Gao S, Liang S, Jotwani R, Zhou H, et al. The role of JAK-3 in regulating TLR-medi-
ated inflammatory cytokine production in innate immune cells. J Immunol. 2013; 191(3):1164–1174.
https://doi.org/10.4049/jimmunol.1203084 PMID: 23797672
52. Zhu C, Gagnidze K, Gemberling JH, Plevy SE. Characterization of an activation protein-1-binding site in
the murine interleukin-12p40 promoter. Demonstration of novel functional elements by a reductionist
approach. J Biol Chem. 2001; 276(21):18519–18528. https://doi.org/10.1074/jbc.M100440200 PMID:
11279072
53. Mitsuhashi M, Liu J, Cao S, Shi X, Ma X. Regulation of interleukin 12 gene expression and its anti-tumor
activities by prostaglandin E2 derived from mammary carcinomas. J Leukoc Biol. 2004; 76(2):322–332
https://doi.org/10.1189/jlb.1203641 PMID: 15123779
54. Yang SK, Wang YC, Chao CC, Chuang YJ, Lan CY, Chen BS. Dynamic cross-talk analysis among
TNF-R, TLR-4 and IL-1R signalings in TNFα-induced inflammatory responses. BMC Med Genomics
2010; 3:19. https://doi.org/10.1186/1755-8794-3-19 PMID: 20497537
55. Kondo T, Kawai T, Akira S. Dissecting negative regulation of Toll-like receptor signaling. Trends Immu-
nol. 2012; 33(9):449–458. https://doi.org/10.1016/j.it.2012.05.002 PMID: 22721918
Dendritic cell, TNFRp55 and reactive arthritis
PLOS ONE | https://doi.org/10.1371/journal.pone.0193573 March 1, 2018 19 / 19
